Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial - Concepedia

Concepedia

Publication | Open Access

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

DOI Full Paper Access

20

Citations

26

References

2023

Year

Lisa Seekircher, Zoltán Bánki, Janine Kimpel, Annika Rössler, Helena Schäfer, Barbara Falkensammer, David Bante, Lukas Forer, Sebastian Schönherr, Peter Willeit

The Lancet Microbe

References

	Year	Citations

Page 1